Enhanced Lithotripsy System (ELS) Clinical Study

Current Study Overview

Avvio Medical is conducting a prospective, multi-center, single-arm clinical trial to evaluate the safety and efficacy of the Enhanced Lithotripsy System (ELS) for the fragmentation of urinary stones in the ureter (proximal, middle, and distal). This study represents a significant step in advancing stone treatment technology, offering a potential new solution for patients suffering from ureteral stones. 

Procedure Animation

Find a Participating Center

To find a participating site, please contact the site directly using the information provided. Don’t see a location close to you? Send us a note at info@avviomed.com — we’d be happy to help.

LocationCity, StatePhoneEmailID
Arkansas Urology Research CenterLittle Rock, AR(501) 830-8050AURC225
AZ State Urological Research InstituteChandler, AZ(602) 842-5305dbaldonado@asuri.netASURI211
Comprehensive Urologic CareLake Barrington, IL(847) 382-5080CUC204
Dr. Mohamed BidairSan Diego, CA(619) 287-6000 or (619) 299-9530SDST213
Georgia UrologyAtlanta, GA(404) 943-9654researchteam@gaurology.comGAU234
Golden State UrologySacramento, CA(916) 245-8888 x308GSU209
Minnesota Urology Bloomington, MN(651) 999-7032eogbu@mnurology.comMNU233
Syracuse University NY, Dr. Scott WeinerSyracuse, NY(585) 275-2838SUNY206
University of MiamiMiami, FL(305) 243-3593ecortizas@med.miami.eduUMH229
Urology NebraskaLincoln, NE(402) 275-2474aaument@folioclinicalresearch.comNEU236
Urology of NevadaReno, NV(702) 823-8965avollmer@urologynevada.comNVU235
University of Rochester, Dr. Rajit JainRochester, NY(585) 275-0126urmcurologyclinicalresearch@urmc.rochester.eduURMC231
Urology of San AntonioSan Antonio, TX(210) 617-4116USA218
Urology of VirginiaVirginia Beach, VA(757) 452-3463JCsenar@urologyofva.netUov202
Urology Specialists ClinicSioux Falls, SD(605) 307-7430ajohnson@folioclinicalresearch.comSDU237

CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. Avvio Medical, Inc. does not currently offer medical devices for sale or distribution and the company’s technology has not received market clearance status by the U.S. FDA or any other country’s regulatory authority.
MKT-0006-03-01 Rev Q, May 2026